1. Home
  2. MIND vs MAIA Comparison

MIND vs MAIA Comparison

Compare MIND & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$7.02

Market Cap

83.4M

Sector

Industrials

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.30

Market Cap

77.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIND
MAIA
Founded
1987
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.4M
77.1M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
MIND
MAIA
Price
$7.02
$1.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
122.5K
547.8K
Earning Date
04-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.31
N/A
Revenue Next Year
$1.01
N/A
P/E Ratio
$22.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.51
$0.87
52 Week High
$14.50
$3.19

Technical Indicators

Market Signals
Indicator
MIND
MAIA
Relative Strength Index (RSI) 51.35 47.43
Support Level $6.50 $1.24
Resistance Level $9.22 $1.46
Average True Range (ATR) 0.35 0.08
MACD 0.09 0.00
Stochastic Oscillator 64.72 33.19

Price Performance

Historical Comparison
MIND
MAIA

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: